Pure Financial Advisors LLC cut its stake in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) by 15.2% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,878 shares of the company’s stock after selling 337 shares during the period. Pure Financial Advisors LLC’s holdings in Elevance Health were worth $693,000 as of its most recent SEC filing.
A number of other hedge funds also recently added to or reduced their stakes in ELV. Leonard Rickey Investment Advisors P.L.L.C. raised its stake in shares of Elevance Health by 3.4% during the fourth quarter. Leonard Rickey Investment Advisors P.L.L.C. now owns 1,061 shares of the company’s stock worth $391,000 after purchasing an additional 35 shares during the last quarter. AMI Investment Management Inc. raised its position in Elevance Health by 78.3% during the 4th quarter. AMI Investment Management Inc. now owns 4,435 shares of the company’s stock worth $1,636,000 after buying an additional 1,947 shares during the last quarter. UMB Bank n.a. lifted its stake in shares of Elevance Health by 11.0% in the 4th quarter. UMB Bank n.a. now owns 2,752 shares of the company’s stock worth $1,015,000 after acquiring an additional 273 shares during the period. Willner & Heller LLC boosted its holdings in shares of Elevance Health by 4.8% in the fourth quarter. Willner & Heller LLC now owns 2,092 shares of the company’s stock valued at $772,000 after acquiring an additional 95 shares in the last quarter. Finally, Diversify Advisory Services LLC raised its holdings in Elevance Health by 13.1% during the fourth quarter. Diversify Advisory Services LLC now owns 793 shares of the company’s stock worth $302,000 after purchasing an additional 92 shares in the last quarter. 89.24% of the stock is owned by institutional investors and hedge funds.
Elevance Health Stock Performance
NYSE ELV opened at $389.45 on Wednesday. The company has a quick ratio of 1.50, a current ratio of 1.50 and a debt-to-equity ratio of 0.56. Elevance Health, Inc. has a fifty-two week low of $362.21 and a fifty-two week high of $567.26. The business has a fifty day moving average of $387.20 and a 200-day moving average of $465.15. The stock has a market cap of $90.32 billion, a price-to-earnings ratio of 14.20, a price-to-earnings-growth ratio of 1.09 and a beta of 0.84.
Analysts Set New Price Targets
Check Out Our Latest Stock Report on ELV
Elevance Health Company Profile
Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
Featured Articles
- Five stocks we like better than Elevance Health
- What Does a Stock Split Mean?
- SAP’s Strong Momentum: A Bullish Setup for Investors
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- Following Congress Stock Trades
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.